159 related articles for article (PubMed ID: 16770759)
21. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ;
J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670
[TBL] [Abstract][Full Text] [Related]
22. Significant association between Nijmegen breakage syndrome 1 657del5 polymorphism and breast cancer risk.
Zhang G; Zeng Y; Liu Z; Wei W
Tumour Biol; 2013 Oct; 34(5):2753-7. PubMed ID: 23765759
[TBL] [Abstract][Full Text] [Related]
23. Clinical characteristics of breast cancer in patients with an NBS1 mutation.
Huzarski T; Cybulski C; Jakubowska A; Byrski T; Gronwald J; Domagała P; Szwiec M; Godlewski D; Kilar E; Marczyk E; Siołek M; Gorski B; Wiśniowski R; Janiszewska H; Surdyka D; Sibilski R; Sun P; Narod SA; Lubiński J;
Breast Cancer Res Treat; 2013 Oct; 141(3):471-6. PubMed ID: 24072268
[TBL] [Abstract][Full Text] [Related]
24. Low frequency of the CHEK2*1100delC mutation among breast cancer probands from three regions of Poland.
Kwiatkowska E; Skasko E; Niwinska A; Wojciechowska-Lacka A; Rachtan J; Molong L; Nowakowska D; Konopka B; Janiec-Jankowska A; Paszko Z; Steffen J
Neoplasma; 2006; 53(4):305-8. PubMed ID: 16830057
[TBL] [Abstract][Full Text] [Related]
25. Germline mutations in the BRCA1 gene predisposing to breast and ovarian cancers in Upper Silesia population.
Grzybowska E; Siemińska M; Zientek H; Kalinowska E; Michalska J; Utracka-Hutka B; Rogozińska-Szczepka J; Kaźmierczak-Maciejewska M
Acta Biochim Pol; 2002; 49(2):351-6. PubMed ID: 12362976
[TBL] [Abstract][Full Text] [Related]
26. NBS1 is a prostate cancer susceptibility gene.
Cybulski C; Górski B; Debniak T; Gliniewicz B; Mierzejewski M; Masojć B; Jakubowska A; Matyjasik J; Złowocka E; Sikorski A; Narod SA; Lubiński J
Cancer Res; 2004 Feb; 64(4):1215-9. PubMed ID: 14973119
[TBL] [Abstract][Full Text] [Related]
27. NBN 657del5 heterozygous mutations and colorectal cancer risk in the Czech Republic.
Pardini B; Naccarati A; Polakova V; Smerhovsky Z; Hlavata I; Soucek P; Novotny J; Vodickova L; Tomanova V; Landi S; Vodicka P
Mutat Res; 2009 Jun; 666(1-2):64-7. PubMed ID: 19393249
[TBL] [Abstract][Full Text] [Related]
28. Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.
Satagopan JM; Boyd J; Kauff ND; Robson M; Scheuer L; Narod S; Offit K
Clin Cancer Res; 2002 Dec; 8(12):3776-81. PubMed ID: 12473589
[TBL] [Abstract][Full Text] [Related]
29. High incidence of BRCA1-2 germline mutations, previous breast cancer and familial cancer history in Jewish patients with uterine serous papillary carcinoma.
Biron-Shental T; Drucker L; Altaras M; Bernheim J; Fishman A
Eur J Surg Oncol; 2006 Dec; 32(10):1097-100. PubMed ID: 16650962
[TBL] [Abstract][Full Text] [Related]
30. [The prevalence of BRCA1 mutations among families at high-risk of breast and ovarian cancer in province of Malopolska between 2004-2009].
Blecharz P; Szatkowski W; Klimek M; Urbański K
Przegl Lek; 2009; 66(12):1046-8. PubMed ID: 20514903
[TBL] [Abstract][Full Text] [Related]
31. Current evidence on the relationship between two polymorphisms in the NBS1 gene and breast cancer risk: a meta-analysis.
Zhang ZH; Yang LS; Huang F; Hao JH; Su PY; Sun YH
Asian Pac J Cancer Prev; 2012; 13(11):5375-9. PubMed ID: 23317186
[TBL] [Abstract][Full Text] [Related]
32. Prophylactic oophorectomy reduces breast cancer penetrance during prospective, long-term follow-up of BRCA1 mutation carriers.
Kramer JL; Velazquez IA; Chen BE; Rosenberg PS; Struewing JP; Greene MH
J Clin Oncol; 2005 Dec; 23(34):8629-35. PubMed ID: 16314625
[TBL] [Abstract][Full Text] [Related]
33. Cancer risk in Jewish BRCA1 and BRCA2 mutation carriers: effects of oral contraceptive use and parental origin of mutation.
Bernholtz S; Laitman Y; Kaufman B; Paluch Shimon S; Friedman E
Breast Cancer Res Treat; 2011 Sep; 129(2):557-63. PubMed ID: 21499684
[TBL] [Abstract][Full Text] [Related]
34. ATM germline mutations in women with familial breast cancer and a relative with haematological malignancy.
Paglia LL; Laugé A; Weber J; Champ J; Cavaciuti E; Russo A; Viovy JL; Stoppa-Lyonnet D
Breast Cancer Res Treat; 2010 Jan; 119(2):443-52. PubMed ID: 19404735
[TBL] [Abstract][Full Text] [Related]
35. Functional variants in NBS1 and cancer risk: evidence from a meta-analysis of 60 publications with 111 individual studies.
Gao P; Ma N; Li M; Tian QB; Liu DW
Mutagenesis; 2013 Nov; 28(6):683-97. PubMed ID: 24113799
[TBL] [Abstract][Full Text] [Related]
36. High frequency of BRCA1/2 germline mutations in consecutive ovarian cancer patients in Poland.
Brozek I; Ochman K; Debniak J; Morzuch L; Ratajska M; Stepnowska M; Stukan M; Emerich J; Limon J
Gynecol Oncol; 2008 Feb; 108(2):433-7. PubMed ID: 17997147
[TBL] [Abstract][Full Text] [Related]
37. Germline mutations 657del5 and 643C>T (R215W) in NBN are not likely to be associated with increased risk of breast cancer in Czech women.
Mateju M; Kleiblova P; Kleibl Z; Janatova M; Soukupova J; Ticha I; Novotny J; Pohlreich P
Breast Cancer Res Treat; 2012 Jun; 133(2):809-11. PubMed ID: 22491912
[No Abstract] [Full Text] [Related]
38. Impact of a paternal origin of germline BRCA1/2 mutations on the age at breast and ovarian cancer diagnosis in a Southern Swedish cohort.
Ellberg C; Jernström H; Broberg P; Borg Å; Olsson H
Genes Chromosomes Cancer; 2015 Jan; 54(1):39-50. PubMed ID: 25251729
[TBL] [Abstract][Full Text] [Related]
39. Breast cancer prognosis in BRCA1 and BRCA2 mutation carriers: an International Prospective Breast Cancer Family Registry population-based cohort study.
Goodwin PJ; Phillips KA; West DW; Ennis M; Hopper JL; John EM; O'Malley FP; Milne RL; Andrulis IL; Friedlander ML; Southey MC; Apicella C; Giles GG; Longacre TA
J Clin Oncol; 2012 Jan; 30(1):19-26. PubMed ID: 22147742
[TBL] [Abstract][Full Text] [Related]
40. Heterozygous germline mutations in NBS1 among Korean patients with high-risk breast cancer negative for BRCA1/2 mutation.
Kim H; Cho DY; Choi DH; Jung GH; Shin I; Park W; Huh SJ; Kim SW; Park SK; Lee JW; Nam SJ; Lee JE; Gil WH; Kim SW
Fam Cancer; 2015 Sep; 14(3):365-71. PubMed ID: 25712764
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
